# FDA recall D-0169-2017

> **Hospira Inc.** · Class III · drug recall initiated 2016-06-29.

## Product

5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01

## Reason for recall

Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.

## Distribution

US and Puerto Rico

## Key facts

- **Recall number:** D-0169-2017
- **Recalling firm:** Hospira Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-06-29
- **Report date:** 2016-12-14
- **Termination date:** 2019-11-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0169-2017

## Citation

> AI Analytics. FDA recall D-0169-2017. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0169-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*